Dizlin Competitors and Similar CompaniesClear all

AFFiRiS's competitors and similar companies include Addex Therapeutics and AlzeCure Pharma.
AFFiRiS
AFFiRiS
AFFiRiS is a company that delivers therapies to patients with neurodegenerative diseases.
Addex Therapeutics
Addex Therapeutics
Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.
AlzeCure Pharma
AlzeCure Pharma
AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders.
Founding Date
Founding Date
2003
Founding Date
2002
Founding Date
2012
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Wien, AT HQ
Locations
Plan-les-Ouates, CH HQ
San Francisco, US
Locations
Huddinge, SE HQ
Employees
Employees
3
Employees
23
Employees
11

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
CHF404k (FY, 2024)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
CHF449k (FY, 2024)
Gross profit
kr1.6m (FY, 2025)
Net income
Net income
N/A
Net income
(CHF6.9m) (FY, 2024)
Net income
(kr47.7m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 34.1m
Total funding raised
$ 94.7m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Addex Therapeutics
HQ
Plan-les-Ouates, CH
Employees
23

Addex Therapeutics, a development-stage biopharmaceutical company, discovers small-molecule pharmaceutical products.

View company
AlzeCure Pharma
HQ
Huddinge, SE
Employees
11

AlzeCure Pharma is a company developing diagnostics and therapeutics for Parkinson’s, Alzheimer’s diseases, and related neurodegenerative disorders.

View company